Eurofins Transplant Genomics
Improving Transplant Recipient Outcomes
health AI / diagnostic molecular testing for organ transplantation
StageAcquired
Raised$20.6M
Founded2013
Employees34
LocationFramingham, MA
About
Eurofins Transplant Genomics develops molecular diagnostic tests for organ transplant monitoring using peripheral blood gene expression profiling and dd-cfDNA analysis. The company serves transplant centers, nephrologists, and transplant surgeons with tests including TruGraf Kidney for subclinical acute rejection surveillance, TRAC Kidney for clinical acute rejection, and OmniGraf Liver for immunosuppression optimization, designed to detect early graft injury and guide therapy decisions.
Product
- Value proposition
- Noninvasive diagnostics guided by genetic biomarkers to detect early graft injury, differentiate actionable causes, and optimize therapy to improve transplant outcomes.
- Target customers
- transplant centers, nephrologists, transplant surgeons, hospital labs
Founders
- Michael Abecassis — Co-Founder
- Dan Salomon — Co-Founder
- Stan Rose — Co-Founder
Categories
BiotechMedtechHealthcare DiagnosticsGenetic Biomarkers
Products
molecular diagnostic tests for transplant monitoringperipheral blood gene expression profilingdd-cfDNA monitoringTRUGRAF kidneyOmnigraf livereurofins TRAC (kidney)our-tests/kidneyour-tests/liverbiomarker-science
Key features
noninvasive diagnosticsearly detection of graft injurydifferentiation of causes of graft injurytherapy optimization guidanceliving and deceased donor compatibility assessment
Technologies
genetic biomarker profilinggene expression profilingdd-cfDNAtrugrafomnigrafeurofins tracbiomarker science
Target conditions
organ transplant complicationsgraft rejectionkidney transplant outcomesliver transplant outcomes
Care settings
hospitalcliniclaboratoryvirtual care
Investors
Eurofins ScientificRose Ventures
News
- Eurofins TRAC™ plus ID - Transplant Genomics · 2024-11-26T20:31:06.000Z
- TRAC ID: Transforming Transplant Monitoring With Precision Biomarkers - Transplant Genomics · 2025-02-06T15:36:26.000Z
- Northwestern Startups: Innovation Commercialization · 2025-11-05T00:00:00.000Z
- TRAC ID: A Clinician's View on the Next Evolution in Molecular Biomarkers - Transplant Genomics · 2025-02-13T15:39:00.000Z
- How OmniGraf Improves Liver Transplant Monitoring · 2024-11-13T00:00:00.000Z
- Customer Memo: Updates to the Eurofins TRAC ID Report - Transplant Genomics · 2025-10-21T09:00:00.000Z
More links
Browse similar startups
Related startups
- Eyebot — Boston, MA
- Eyewell — Boston, MA
- Fable Therapeutics — Cambridge, MA
- FlowRx.ai — Needham, MA
- Genomes2People — Boston, MA
- Gordion Bioscience — Boston, MA
- EverBetter, LLC — Brentwood, TN
- Evercrisp Biosciences — Berkeley, CA
- eVitals Remote Patient Monitoring — Sherman, TX
- EVRKind™ — The Caregiver Operating System — Minneapolis, MN
- Evvy — New York, NY
- Exactics, Inc. — Chicago, IL
Profile updated Jul 29, 2026. Sources: transplantgenomics.com, linkedin.com
